Beijing (1)

Advanced Non Squamous NSCLC (1)

Recruiting (1)

phase 2 (1)

Junling Li (1)

apatinib (1)

camrelizumab (1)

drug (1)

Other (1)

Interventional (1)

advanced non squamous nsclc

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Jun 27, 2021